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Prefrontal cortex markers of suicidal vulnerability in mood
disorders: a model-based structural neuroimaging study with a
translational perspective
Y Ding1, N Lawrence2, E Olié3, F Cyprien3, E le Bars4, A Bonafé4, ML Phillips5, P Courtet3 and F Jollant1,6
The vulnerability to suicidal behavior has been modeled in deﬁcits in both valuation and cognitive control processes, mediated by
ventral and dorsal prefrontal cortices. To uncover potential markers of suicidality based on this model, we measured several brain
morphometric parameters using 1.5T magnetic resonance imaging in a large sample and in a speciﬁcally designed study. We then
tested their classiﬁcatory properties. Three groups were compared: euthymic suicide attempters with a past history of mood
disorders and suicidal behavior (N= 67); patient controls with a past history of mood disorders but not suicidal behavior (N= 82);
healthy controls without any history of mental disorder (N= 82). A hypothesis-driven region-of-interest approach was applied
targeting the orbitofrontal cortex (OFC), ventrolateral (VLPFC), dorsal (DPFC) and medial (including anterior cingulate cortex; MPFC)
prefrontal cortices. Both voxel-based (SPM8) and surface-based morphometry (Freesurfer) analyses were used to comprehensively
evaluate cortical gray matter measure, volume, surface area and thickness. Reduced left VLPFC volume in attempters vs both
patient groups was found (P= 0.001, surviving multiple comparison correction, Cohen’s d = 0.65 95% (0.33–0.99) between
attempters and healthy controls). In addition, reduced measures in OFC and DPFC, but not MPFC, were found with moderate effect
sizes in suicide attempters vs healthy controls (Cohen’s d between 0.34 and 0.52). Several of these measures were correlated with
suicidal variables. When added to mood disorder history, left VLPFC volume increased within-sample speciﬁcity in identifying
attempters in a signiﬁcant but limited way. Our study, therefore, conﬁrms structural prefrontal alterations in individuals with
histories of suicide attempts. A future clinical application of these markers will, however, necessitate further research.
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INTRODUCTION
One million individuals commit suicide each year worldwide.1
Improving our ability to predict and subsequently prevent it has
become an important priority. However, the current assessment of
suicide risk is based upon numerous socio-demographic and
clinical risk factors often yielding a high sensitivity but a low
speciﬁcity.2 It is expected that using speciﬁc neurobiological
markers, in addition to the clinical assessment, may improve the
future evaluation of suicide risk. Uncovering some of these
biomarkers is the goal of the present study.
The current understanding of suicidal behavior is based on a
stress-vulnerability model, which suggests that some individuals
are at higher risk of committing suicide in stressful situations like
interpersonal conﬂicts or loss.3 This model has been supported by
in vivo neuroimaging studies.4 When comparing suicide attempt-
ers (SAs) with patient controls (PCs) and/or healthy controls (HCs),
functional neuroimaging studies have revealed dysfunctional
ventral, dorsomedial and dorsolateral prefrontal cortices among
other regions in various conditions, from resting state5 to viewing
angry faces,6 making decisions7 or listening to suicidal scripts.8
Finally, structural neuroimaging has reported various brain
alterations in SAs, affecting both gray and white matter (see
below).
On the basis of this literature, we recently proposed a
neuroanatomical model accounting for the vulnerability to
suicidal behavior at the neurocognitive level.4 In this model, we
suggested that the ventral prefrontal cortex including the
orbitofrontal cortex (OFC) would be mainly implicated in valuation
deﬁcits, explaining decision-making impairments in SAs,9 while
more dorsal parts of the prefrontal cortex (including anterior
cingulate cortex, ACC) may explain deﬁcits in cognitive control
and emotion regulation processes.10 In the present study, we
aimed at conﬁrming the involvement of these prefrontal brain
regions, and their potential as biomarkers, by examining their
morphometric properties using structural neuroimaging in a large
sample. Certainly, the ease of implementing structural neuroimag-
ing compared with functional neuroimaging is potentially a great
advantage and highly relevant for future clinical application.
However, previous results using this technique suffer from
various limitations. First, many studies assessed samples of small
size, as few as seven to ten SAs.11,12 Only one large study, in
psychotic disorders, has been published to date.13 Recent papers
have highlighted a frequent lack of replication of ﬁndings in
neuroscience, partly in relation to underpowered studies.14
Second, of the six published studies evaluating whole-brain gray
matter alterations, six different types of statistical thresholds have
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been used.15–20 However, recent discussions about the lack of
reliability of the P-value suggest that calculating effect sizes may
be a more relevant approach.21 Third, these studies have focused
on one particular standard analysis method, usually measuring
brain volume differences using voxel-based morphometry (VBM),
but have seldom applied concurrent surface-based morphometry
(SBM) analyses. Only two studies explored cortical thickness to
date.13,22 To our knowledge, only one group has combined two
analysis methods in two different publications.15,22 Yet, recent
analyses have suggested that different SBM measures account for
VBM gray matter variation in different regions but also that VBM
may be more sensitive than SBM to detect some abnormalities.23
The combination of both analyses could therefore improve our
understanding of structural neuroimaging markers of disease.
We addressed several of these issues in the present study. First,
we pooled data from three separate studies conducted in two
locations with identical study designs to increase power. This has
resulted in the largest neuroimaging study conducted on
vulnerability to suicidal behavior in mood disorders to date.
Second, we calculated effect sizes for the main contrasts, namely
SAs vs PCs, and SAs vs HCs. Third, we used two complementary
analysis approaches in parallel, namely VBM and SBM. Finally, we
used a validated study group design to speciﬁcally examine the
vulnerability to suicidal behavior by including non-depressed
patients to exclude the acute effects of the depressive state, and a
group of patients with a history of mood disorder but no suicide
attempt to exclude the effect of comorbid disorders.
On the basis of previous studies, we hypothesized that SAs
when compared with control groups would show a reduction in
structural measures of prefrontal cortex. To test the potential
clinical applicability of these measures, we additionally conducted
sensitivity and speciﬁcity calculations.
MATERIALS AND METHODS
Samples and assessment
Three samples were recruited, one at the Institute of Psychiatry in London,
UK (Sample 1), and two at the academic hospital of Montpellier, France
(Samples 2 and 3). For all the three samples, participants were recruited
through advertisement with an initial screening via telephone interview, or
in clinical settings. They were then interviewed in person by experienced
psychiatrists. All participants were right-handed24 and euthymic at the
time of scanning with a HDRS (Hamilton Depression Rating Scale) score
below nine.25 Exclusion criteria were a lifetime history of severe head
trauma, central nervous system disorders, schizophrenia and substance use
disorder over the last 12 months, suicide attempt using ﬁrearms,
pregnancy and contraindications to magnetic resonance imaging (MRI).
Details on exclusions from each sample are given in Supplementary
Information.
The three samples differed in two selection criteria: (1) Samples 1 and 2
comprised only males aged between 18 and 60, whereas Sample 3
comprised only non-menopausal females aged between 18 and 50; (2) All
patients in Sample 1 suffered from major depressive disorder, whereas
Samples 2 and 3 included both major depressive disorder and bipolar
disorders.
All diagnoses were made according to the Diagnostic and Statistical
Manual of Mental Disorders IV criteria using the Mini-International
Neuropsychiatric Interview, version 5.0.0.26 The French or English versions
of the National Adult Reading Test27 were used to provide an estimation of
verbal IQ and the Beck Depression Inventory28 for a subjective measure of
current depressive state. Participants also completed the Barratt Impul-
siveness Scale version 10.29
Within each sample, three groups were recruited as described above: (1)
SAs, individuals with a personal history of both mood disorder and suicidal
behavior; (2) PCs, individuals with a history of mood disorder but no
lifetime history of suicidal behavior; (3) HCs, individuals with no current or
past history of any Diagnostic and Statistical Manual of Mental Disorders IV
Axis I diagnoses or suicidal behavior or psychotropic medication. The
overall population included 82 HCs, 82 PCs and 67 SAs.
As in our previous studies, suicidal act was deﬁned as any nonfatal, self-
directed potentially injurious behaviors with any intent to die as a result.3
The last and the most severe suicidal acts were assessed using the Risk
Rescue Rating Scale30 and the Suicide Intent Scale.31
Participants from Sample 3 additionally fullﬁlled the Childhood Trauma
Questionaire,32 and participants from Sample 1 played the Iowa Gambling
Task, a decision-making test.33
After complete description of the study to the subjects, written informed
consent was obtained from all the participants. The studies were approved
by the respective Research Ethics Committee (Institute of Psychiatry and
Montpellier Research Ethics Board). The participants were paid £30 and
€100, respectively.
Functional neuroimaging and behavioral results (but not structural
results) from Sample 1 have previously been published6,7 but data from
Samples 2 and 3 have not.
MRI acquisition procedures
For Sample 1, T1-weighted magnetic resonance images were acquired
using a GE Signa 1.5 T Neuro-optimized MR system (General Electric,
Milwaukee, WI, USA) at the Institute of Psychiatry, London, UK. A spoiled
gradient echo sequence was used for the T1-weighted acquisition with the
following parameters: isotropic voxel dimension of 1.1 mm with ﬁeld-of-
view at 280× 180mm; TE (echo time) of 5 ms and TR (repetition time) of
10.8 ms. Two-dimensional matrix 256× 160 with 150 slices acquired,
bandwidth of 122 Hz per pixel.
For Samples 2 and 3, T1-weighted magnetic resonance images were
acquired with a 1.5 T whole-body MRI system (MAGNETON AVANTO,
Siemens, Erlangen, Germany) in Montpellier Academic Hospital, France.
Sample 2 used three-dimensional T1 FLASH sequence with voxel
dimension of 0.93 × 0.93 × 1mm, ﬁeld-of-view at 240× 240mm, matrix
256× 256, 15 degrees ﬂip angle, TE of 5.2 ms and TR of 11ms with 160
slices, bandwidth of 130 Hz per pixel. Sample 3 used three-dimensional T1
MPRAGE with voxel dimension of 0.98mm×0.98mm×1mm, ﬁeld-of-view
at 250× 250mm, matrix 256× 256 with 160 slices, 15 degrees ﬂip angle, TE
of 4.1 ms, TR of 2100ms and TI of 1100ms, bandwidth of 140 Hz per pixel.
MRI analyses
We conducted VBM analyses using SPM8 v.4667, and SBM analyses with
FreeSurfer 5.1.0. (Details in the Supplementary Information). In brief, after
quality control checks, SPM segments the T1 structural data and produces
a group template based on the entire group data set by nonlinearly
warping each participant to the common brain template space while
preserving local anatomical alterations. VBM analyses yield normalized
gray matter volume measurement since it is sampled in template MNI
space, not the individual space before normalization. In contrast, Freesurfer
registers each vertices at individual gyrus/sulcus level to template but
ultimately produce individualized measurement of volume, area and
surface based on personally modeled brain morphometry and gray matter/
white matter boundary contours. VBM data were smoothed using an 8-mm
full width at half maximum Gaussian kernel in volume space, whereas SBM
data were smoothed using 20mm full width at half maximum Gaussian
kernel in surface space to maximize sensitivities toward smaller clusters of
structural differences as suggested by previous studies testing variety of
full width at half maximum sizes in different sample sizes.34,35
We used a region-of-interest (ROI) approach due to robust a priori
hypotheses17 and its elevated statistical sensitivity. Four ROIs (Figure 1)
were deﬁned using independently a priori deﬁned anatomical atlases
(detailed in Supplementary Information), on the basis of regions previously
reported to show structural and/or functional alterations associated with
suicidal behavior, and differentiated on the basis of different brain
connections36 and functional roles notably in valuation processes and
cognitive control:37,38 (1) the OFC,6,7,12,13 (corresponding to the lateral part
of Brodmann areas (BAs) 11, and BA 47); (2) the ventrolateral prefrontal
cortex (referred to as VLPFC and corresponding to BA 44 and 45);39 (3) the
ventromedial prefrontal cortex (including the medial part of BA 11, BA 10
and the ACC, both rostral and dorsal parts (BA 24/32); ROI referred to
medial prefrontal cortex, MPFC)15 and (4) the dorsal and lateral prefrontal
cortex (referred to as DPFC and corresponding to BA 46/8/9).5,19,20 Average
measures of all the voxels (for VBM) or vertex (for SBM) measures within
that ROI were used.
Although multi-site neuroimaging poses challenges, samples can be
combined and analyzed when groups are balanced across samples (which
is the case here) and samples multi-site are properly controlled for in the
analysis.40,41 The total volume and surface area, and the average thickness
in individual space and normalized gray matter volume in template space
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for each ROI were extracted and analyzed after covarying for relevant
covariables consecutively. Group comparisons in normalized gray matter
volume, and SBM volumes/areas were systematically controlled for
intracranial volume.42
Statistical analyses
General linear model, followed by Tukey’s post hoc, were used to compare
quantitative variables between groups, and Pearson’s correlation to
examine associations between quantitative variables. Qualitative variables
were compared using χ2 tests.
We additionally calculated effect sizes (Cohen’s d) and its 95%
conﬁdence interval based on marginal means and standard error output
from the general linear model (after accounting for the appropriate
covariates) for the main contrasts between SA and both control groups.
A binary logistic regression model was used for sensitivity and speciﬁcity
analyses.
When applying, the alpha level was set at 0.05 unless a Bonferroni
correction was necessary. The threshold for ROI analyses was set at a very
conservative Bonferroni-corrected Po0.002 (Po0.05 divided by four ROIs,
two sides and four different measures).
Statistical analyses were carried out with SPSS 20 (SPSS, Chicago,
IL, USA).
RESULTS
Socio-demographic and clinical variables
Groups were equally distributed across samples (see
Supplementary Information). Similar between-groups differences
were observed across all three samples and the pooled sample
(Table 1). Although euthymic, HDRS and Beck Depression
Inventory scores were higher in patients as expected. These
variables were not used as covariates as they are related to the
group proﬁle. Level of education was higher in HCs than SAs.
Moreover, there were more males in HC than both patient groups.
SAs did not differ signiﬁcantly from PCs on socio-demographic
or clinical variables. However, they received signiﬁcantly more
antipsychotics with a trend for more anxiolytics/hypnotics. Most
suicidal acts (85%) were drug overdose.
Neuroimaging ﬁndings
Voxel-based morphometry. See Table 2 for group comparisons of
all measures, Figure 2 for effect size analyses and Figure 3 for a
correlation map between all measured examined here.
After covarying for sample and intracranial volume, general
linear models based on normalized cortical gray matter volumes
showed between-group differences in left VLPFC (P= 0.01), left
OFC (P= 0.03) and right DPFC (P= 0.04), but not MPFC, although
nonsigniﬁcant after multiple comparison correction. Post hoc
analyses showed decreased normalized regional measures in SAs
relative to HCs with no signiﬁcant differences between SAs and
PCs, and between HCs and PCs. Effect size calculation additionally
suggests a signiﬁcant effect between SAs and HCs for left DPFC,
right VLPFC, right OFC and right MPFC (Figure 2).
In exploratory whole-brain VBM analyses, SPM revealed lower
measure in SAs than PCs in right lateral OFC (BA 47; family-wise
error-corrected cluster P-value = 0.03; peak voxel = 48, 21, 0; cluster
size = 1).
Figure 1. Representation of the four regions-of-interest of the prefrontal cortex examined in this article. Blue: medial prefrontal cortex (MPFC;
including anterior cingulate cortex, not shown); red: dorsal prefrontal cortex (DPFC); green: orbitofrontal cortex (OFC); violet: ventrolateral
prefrontal cortex (VLPFC). VBM, voxel-based morphometry.
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Surface-based morphometry. After covarying for sample and
intracranial volume, there were group differences in gray matter
volume in left VLPFC (P= 0.001, surviving multiple comparison
correction) with reduced volume in SAs vs both control groups,
and between PCs and HCs, and right DPFC (P= 0.03, not surviving
multiple comparison correction), with reduced measures in SAs vs
HCs. There was no difference for OFC or MPFC. Effect size
calculation additionally suggests a signiﬁcant effect between SAs
and HCs for left DPFC and right VLPFC.
After covarying for sample and intracranial volume, there were
group differences in gray matter area in left VLPFC (P= 0.01, not
surviving multiple comparison correction), with reduced measures
in SAs vs HCs, but not in OFC, DPFC or MPFC.
After covarying for sample only, there were group differences in
thickness in right VLPFC (P= 0.04, not surviving multiple
comparison correction) with reduced measure in SAs vs HCs, but
not in OFC, DPFC or MPFC. Effect size calculation additionally
suggests a signiﬁcant effect between SA and HC for right DPFC.
Figure 3 shows that structural measures were highly inter-
correlated, notably SBM volumes together and area measures
together. Only thickness measures were poorly correlated with
area or volume measures as expected.
Effect of covariates. Only left VLPFC SBM volume and left VLPFC
area remained signiﬁcant after controlling for all main covariates
(age, gender, level of education, bipolar disorder, lithium or
antipsychotic intake). Left VLPFC VBM volume was not signi-
ﬁcant anymore when covarying for gender or bipolar disorder;
left OFC VBM volume for age, gender, bipolar disorder or lithium;
right DPFC VBM or SBM volumes for age, gender or bipolar
disorder; right VLPFC thickness for bipolar disorder or
antipsychotics.
Correlation with clinical variables. In SAs, lethality of the last
suicidal act was correlated with all measures except left VLPFC
area and right VLPFC thickness (all Po0.05; strongest correlations
with right DPFC VBM and SBM volumes: r=−0.45; Po10− 3;
left OFC: r=−0.38, P= 0.001; left VLPFC SBM volume: r=−0.33;
P= 0.007); number of suicidal acts was correlated with right DPFC
VBM volume (r=−0.25, P= 0.04) and left OFC VBM (r=−0.24;
P= 0.05); age at ﬁrst suicidal act with right DPFC SBM volume
(r=−0.40; P= 0.001) and right VLPFC thickness (r=−0.26, P= 0.03).
No measure was correlated with Suicide Intent Scale.
In patients, HDRS score was correlated with all measures except
left VLPFC area and right VLPFC thickness (r between −0.15 and
−0.21; all Po0.07); age at ﬁrst mood episode with right VLPFC
thickness only (r=−0.21; P= 0.01); number of mood episodes with
right DPFC SBM volume (r=−0.20, P= 0.01); Barratt Impulsiveness
Scale version 10 total score with all measures except right DPFC
SBM volume (all Po0.07; strongest correlation with left VLPFC
area: r= 0.26, P= 0.001; left OFC: r= 0.23, P= 0.005); and Childhood
Trauma Questionaire total score with right VLPFC thickness
(r=−0.24; P= 0.03). No measure was correlated with Beck
Depression Inventory.
There was no signiﬁcant assocation between the Iowa
Gambling Task total score and any measure, but data were only
available in the small Sample 1.
Potential for clinical application. We examined the sensitivity and
speciﬁcity of the neuroimaging measures in correctly classifying
individuals with histories of suicide attempt among the 231
Table 1. Description and comparison of socio-demographic and clinical variables across the three groups in the pooled sample
Healthy controls
(n=82)
Patient controls
(n= 82)
Suicide attempters
(n= 67)
Omnibus F/χ2/t P Post hoc
Male gender, N (%) 62 (75.6) 43 (52.4) 28 (41.8) 18.6 o0.001 HC 4 PC,
SA
Age, mean (s.d.) 37.8 (8.1) 39.4 (9.7) 39.2 (10.6) 0.8 0.5
Years of education, N (%) 15.5 (2.1) 14.2 (2.5) 13.9 (2.2) 11.3 o0.001 HC 4 PC,
SA
NART (% correct), mean (s.d.) 0.73 (0.14) 0.72 (0.12) 0.69 (0.11) 2.0 0.1
HDRS, mean (s.d.) 0.9 (1.4) 3.6 (2.2) 3.1 (2.3) 41.7 o0.001 HC o PC,
SA
BDI, mean (s.d.) 1.1 (2.5) 5.5 (5.3) 5.1 (4.6) 26.7 o0.001 HC o PC,
SA
Age at ﬁrst mood episode, mean (s.d.) — 25.6 (8.9) 25.3 (11.0) 0.2 0.9
Number of depressive episodes, mean (s.d.) — 5.0 (8.4) 5.6 (8.1) 2320 1.0
Bipolar disorder, N (%) — 30 (36.6) 30 (44.8) 1.0 0.3
Number of hypo(manic) episodes, mean (s.d.) — 3.2 (8.0) 3.8 (9.2) 2389.5 0.3
Anxiety disorders, current, N (%) — 28 (34.1) 27 (40.3) 0.6 0.4
OCD, current, N (%) — 3 (3.7) 0 (0) 2.5 0.1
Alcohol/substance abuse, past, N (%) — 26 (31.7) 16 (23.9) 1.1 0.3
BIS10, mean (s.d.) 60.1 (13.8) 58.6 (16.7) 58.4 (16.6) 0.3 0.8
Psychotropic medication, N (%) — 47 (57.3) 46 (68.7) 2.0 0.2
Antidepressant, N (%) — 25 (30.5) 24 (35.8) 0.5 0.5
Lithium, N (%) — 14 (17.1) 13 (19.4) 0.1 0.7
Antipsychotics, N (%) — 6 (7.3) 17 (25.4) 9.2 0.002 PC o SA
Anticonvulsivants, N (%) — 14 (17.1) 14 (20.9) 0.3 0.6
Anxiolytics and hypnotics, N (%) — 14 (17.1) 20 (29.9) 3.4 0.06
Age at ﬁrst suicide attempt, mean (min-max) — — 27.7 (11–59) — —
Number of suicide attempts, mean (min-max) — — 2.7 (1–10) — —
Suicide intent scale, total score, most severe
act, mean (min-max)
— — 16.2 (8–26) — —
Risk rescue rating scale, total score, most
severe act, mean (min-max)
— — 41.2 (26–57) — —
Abbreviations: BDI, Beck Depression Inventory; BIS10, Barratt Impulsivity Scale Version 10; HC, healthy control; HDRS, Hamilton Depression Rating Scale; NART,
National Adult Reading Test; OCD, obsessive compulsive disorder; PC, patient control; SA, suicide attempter.
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participants. As expected, a history of mood disorder had a 100%
sensitivity (as all SAs suffered from mood disorder in our study)
but a lower speciﬁcity (71%). Adding left VLPFC area or volume
into the model improved speciﬁcity in identifying attempters in a
signiﬁcant but limited manner, reaching 74.9 and 75.3%,
respectively. Other measures had smaller effects. Of note, these
ﬁndings cannot be generalized and may be inﬂated, and should
therefore be seen as indicative of the clinical potential of these
measures when added to clinical signs and symptoms.
DISCUSSION
This study examined structural alterations associated with the
vulnerability to suicidal behavior in mood disorders using two
complementary analyses in 231 subjects including 67 SAs. It
represents the largest neuroimaging study of suicidal behavior in
mood disorders to date and was speciﬁcally designed to
investigate the neural basis of suicidal behavior. After covarying
for sample, intracranial volume, gender, age, education, bipolar
disorder and medication intake, ROI analyses showed signiﬁcant
group differences in left VLPFC volume measured by Freesurfer,
the only measure that discriminated SA from both control groups
in our study. Additional measures in VLPFC, OFC and DPFC,
although not surviving a very conservative multiple comparison
correction, were also different between SAs and HCs, with
moderate effect sizes (Cohen’s d up to 0.50). The link between
these neuroimaging measures and the vulnerability to suicidal
acts is further supported by signiﬁcant correlations with suicidal
variables including suicidal lethality, age at ﬁrst suicidal act and
number of previous acts. It is important to emphasize that patients
were euthymic at the time of scanning, suggesting that these
differences may reﬂect trait-like alterations. Our ﬁndings, there-
fore, tend to support the involvement of structural impairments in
VLPFC, DPFC and OFC, but not MPFC (including ACC), in the
pathophysiology of suicidal behavior.
Our results are in agreement with several results from previous
studies in mood disorders. For dorsal regions, reduced VBM
volumes in DPFC in SAs vs PCs have been reported in bipolar
disorder20 and in elderly individuals with major depressive
disorder.19 Wagner et al.22 also reported reduced cortical thickness
in the same region. Reduced volume of ACC in SAs vs PCs has
been found in depressive disorders,15 bipolar disorder20 but not in
a small sample of depressed women.12 However, our study
showed no structural differences in ACC. For ventral regions,
previous studies have also shown reduced VBM measure20 and
thickness22 in OFC in SAs. Similarly, Wagner et al.22 reported
reduced thickness in a region that encompassed our left VLPFC.
Between-study differences in sample size, choice of threshold and
lack of control for intracranial volume may explain some
discrepancies with previous studies.
The role of these prefrontal regions in suicidal vulnerability has
to be clariﬁed. Two recent meta-analyses conﬁrmed deﬁcits in
decision-making, cognitive control and working and long-term
memory in SA.9,43 The OFC, which receives connections from the
amygdala and thalamus, has a signiﬁcant role in the interpretation
of stimuli in the environment, notably in attributing value to
Table 2. Region-of-interest analyses in the pooled sample comparing the three participant groups
Regions Pipeline Measures Side General linear model
F P Partial eta-squared
Orbitofrontal cortex (OFC) SPM Normalized volume Left 3.50 0.03 0.031
Right 1.89 0.15 0.017
Freesurfer Cortical volume Left 1.32 0.27 0.012
Right 1.00 0.37 0.009
Surface area Left 1.27 0.28 0.011
Right 0.97 0.38 0.009
Cortical thickness Left 0.37 0.70 0.003
Right 0.24 0.79 0.002
Medial prefrontal cortex (MPFC) SPM Normalized volume Left 1.78 0.17 0.016
Right 2.29 0.10 0.020
Freesurfer Cortical volume Left 0.66 0.52 0.006
Right 1.29 0.28 0.012
Surface area Left 0.04 0.96 0.000
Right 0.36 0.70 0.003
Cortical thickness Left 0.20 0.82 0.002
Right 0.88 0.42 0.008
Ventrolateral prefrontal cortex (VLPFC) SPM Normalized volume Left 4.73 0.01 0.041
Right 2.56 0.08 0.023
Freesurfer Cortical volume Left 7.70 0.001a 0.065
Right 2.81 0.06 0.025
Surface area Left 4.39 0.01 0.038
Right 1.14 0.32 0.010
Cortical thickness Left 0.21 0.40 0.008
Right 4.36 0.04 0.029
Dorsal prefrontal cortex (DPFC) SPM Normalized volume Left 2.70 0.07 0.024
Right 3.41 0.04 0.030
Freesurfer Cortical volume Left 2.85 0.06 0.025
Right 3.55 0.03 0.031
Surface area Left 0.42 0.66 0.004
Right 0.56 0.57 0.005
Cortical thickness Left 1.41 0.25 0.013
Right 2.31 0.10 0.020
aSurviving multiple comparison correction. All analyses covarying for sample, and total intracranial volume, except for thickness with only sample as covariate.
Bold entries indicate Po0.05, uncorrected for multiple comparison.
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stimuli (stimuli–outcome association),37 which may be important
for the triggering of the suicidal crisis in the face of environmental
stressors. The lateral PFC receives motivational inputs from ACC44
and represents cognitive information from memory, which is
deﬁcient in SA. Dorsal and lateral PFC notably confronts various
informations to outcomes and, therefore, exert a cognitive control
by ensuring the most advantageous choice in addition to some
forms of behavioral ﬂexibility.37 Dysfunction of this interconnected
prefrontal network may, therefore, be instrumental in the suicidal
process by corrupting information acquisition and processing,
resulting in impaired decision-making. At the clinical level, this
would be reﬂected by negative assessments of life events and the
automatic triggering of intense emotional responses, and the
inability to control the evoked emotional responses and particular
negative thoughts (including hopelessness, ruminations and
suicidal ideas), and to prevent choosing to commit a suicidal act
over alternative options.
At a translational level, our ﬁndings suggest that simple 1.5 T
10-min structural MRI sequences, relatively easy to implement in
clinical practice, are unfortunately not sufﬁcient to differentiate
patients at higher risk of committing a suicidal act from non-
attempters. Although some measures investigated here signiﬁ-
cantly improved within-sample speciﬁcity in identifying SAs
among patients with mood disorders, the improvement was
not sufﬁciently large enough to support clinical application.
Advancements, in terms of acquisition (for example, higher ﬁeld or
multi-morphometric sequences), analysis methods (for example,
quantitative MRI) or examination of particular subregions, are
expected and may also increase accuracy.
One must keep in mind that patients who attempt suicide are
likely a heterogeneous group. Different subgroups of SAs (and
PCs) may, therefore, show different structural alterations. This has
previously been suggested in SAs when comparing decision-
making performance in patients who committed violent vs
nonviolent suicidal acts,45 and for resting-state activity in high
vs low lethality attempters.5 It may be more relevant in future
studies to focus on particular subgroups as suggested,46 for
example, those with particular neurocognitive alterations, and
assess the predictive value of these alterations in prospective
studies and clinical trials. This should notably be tested with the
imaging markers revealed here.
Our study presents several limitations. First, pooled data
analysis adds heterogeneity when not designed a priori as a
multicenter study, due to different acquisition parameters and
scanners, which contributes to increased risk of type II errors47 but
not type I error and does not undermine highlighted ﬁndings.
Second, we included moderately to severely ill and often
medicated patients to be more representative of the general
clinical population. This may have added heterogeneity although
several clinical factors (including bipolar disorder and medication)
were controlled for in analyses. Finally, determination of ROIs
largely depends on their deﬁnition and the atlases, and these only
partly overlap for SBM and VBM. This could explain the lack of
convergence in statistically signiﬁcant results between the two
analysis methods. Our ROIs were also large in size, which may
have reduced our ability to detect more localized differences.
In conclusion, we conﬁrmed the role of several prefrontal
regions in the vulnerability to suicidal behavior. Further research is
Figure 2. Effect sizes between suicide attempters and both control groups for the four regions-of-interest. DPFC, dorsal prefrontal cortex;
MPFC, medial prefrontal cortex; OFC, orbitofrontal cortex; VBM, voxel-based morphometry; VLPFC, ventrolateral prefrontal cortex. Blue:
suicide attempters vs patient controls; black: suicide attempters vs healthy controls.
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nonetheless required for the application of MRI in the prediction
of suicidal behavior.
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